Eom Kirsten Y, Mann Bhupinder, Halpern Michael T
Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Rockville, MD.
Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Rockville, MD.
Urol Oncol. 2025 Mar;43(3):191.e13-191.e27. doi: 10.1016/j.urolonc.2024.11.012. Epub 2024 Dec 9.
Cancer patients often have complex medical needs from diagnosis to survivorship/end-of-life care. Integrated care, including care coordination, multidisciplinary rounds, and supportive care services, is crucial for high-quality cancer care. Yet, factors influencing integrated care receipt are not well understood. This study describes patterns of integrated care among individuals diagnosed with kidney or urinary bladder cancer and examines patient- and hospital-level factors associated with these services.
Analyzing 2019 National Cancer Institute Patterns-of-Care data, we assessed integrated care service receipt among stage I to IV kidney and stage 0a to IVb urinary bladder cancer patients aged ≥ 20 years using a stratified Surveillance, Epidemiology, and End Results registry sample. Integrated care services within 12 months postdiagnosis were identified by medical record abstraction. Multivariable logistic regression analyses identified patient, clinical, and hospital-level factors significantly associated with receipt of integrated care.
Significant variations in receiving integrated care were observed based on insurance status; uninsured patients less likely to receive these services. Racial/ethnic differences were also noted, as non-Hispanic white patients had higher likelihoods of receiving integrated care. Stage IV kidney cancer patients were 2.63 times [1.44-4.79] more likely to receive integrated care than stage I patients. Treatment characteristics and hospital-level factors appeared to have minimal impact on receiving these services.
The lower likelihood of receiving integrated care among patients with no insurance and among certain racial/ethnic groups underscores gaps in equitable access to patient-centered cancer care. Future research should include patient perspectives to enhance understanding of unmet needs and influencing factors related to integrated care services.
癌症患者从诊断到生存/临终关怀往往有复杂的医疗需求。综合护理,包括护理协调、多学科会诊和支持性护理服务,对于高质量的癌症护理至关重要。然而,影响综合护理接受情况的因素尚不清楚。本研究描述了被诊断为肾癌或膀胱癌的个体的综合护理模式,并研究了与这些服务相关的患者和医院层面的因素。
分析2019年美国国立癌症研究所护理模式数据,我们使用分层的监测、流行病学和最终结果登记样本,评估了年龄≥20岁的I至IV期肾癌患者和0a至IVb期膀胱癌患者的综合护理服务接受情况。通过病历摘要确定诊断后12个月内的综合护理服务。多变量逻辑回归分析确定了与综合护理接受情况显著相关的患者、临床和医院层面的因素。
观察到基于保险状况的综合护理接受情况存在显著差异;未参保患者接受这些服务的可能性较小。还注意到种族/民族差异,因为非西班牙裔白人患者接受综合护理的可能性更高。IV期肾癌患者接受综合护理的可能性是I期患者的2.63倍[1.44-4.79]。治疗特征和医院层面的因素似乎对接受这些服务的影响最小。
未参保患者和某些种族/民族群体接受综合护理的可能性较低,这凸显了在以患者为中心的癌症护理公平可及性方面的差距。未来的研究应纳入患者的观点,以增强对未满足需求以及与综合护理服务相关的影响因素的理解。